Neutrophil-to-Lymphocyte Ratio as an Inflammatory Marker in Familial Mediterranean Fever: A Systematic Review and Meta-analysis

Alireza Omranzadeh; Ashkan Baradaran; Alireza Ghodsi; Soheil Arekhi; Malihe Dadgarmoghaddam; Amin Mirshekaran; Amirreza Dehghan Tarazjani; Bahare Fazeli

doi:10.1055/s-0041-1728730

Journal of Child Science, Inhaltsverzeichnis

CC BY 4.0 · Journal of Child Science 2021; 11(01): e100-e109
DOI: 10.1055/s-0041-1728730

Review Article

Neutrophil-to-Lymphocyte Ratio as an Inflammatory Marker in Familial Mediterranean Fever: A Systematic Review and Meta-analysis

Alireza Omranzadeh

¹Student Research Committee, Mashhad University of Medical Sciences, Mashhad, Iran

,

Ashkan Baradaran

¹Student Research Committee, Mashhad University of Medical Sciences, Mashhad, Iran

,

Alireza Ghodsi

¹Student Research Committee, Mashhad University of Medical Sciences, Mashhad, Iran

,

Soheil Arekhi

¹Student Research Committee, Mashhad University of Medical Sciences, Mashhad, Iran

,

Malihe Dadgarmoghaddam

²Community Medicine Department, Medical School, Mashhad University of Medical Sciences, Mashhad, Iran

,

Amin Mirshekaran

¹Student Research Committee, Mashhad University of Medical Sciences, Mashhad, Iran

,

Amirreza Dehghan Tarazjani

¹Student Research Committee, Mashhad University of Medical Sciences, Mashhad, Iran

,

Bahare Fazeli

³Inflammation and Inflammatory Diseases Research Center, Faculty of Medicine, Department of Immunology, Inflammation and Inflammatory Diseases Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

› Institutsangaben

Abstract

Familial Mediterranean fever (FMF) is a genetic disease with inflammatory basis. Several studies have assessed the role of neutrophil-to-lymphocyte ratio (NLR) in detecting this inflammation; however, no systematic review or meta-analysis has assessed these studies together. The aim of this study is to systematically review and meta-analyze the NLR value between FMF patients and normal controls. Scopus, PubMed, Embase, and ISI Web of Science were searched using predesigned search strategy to find the studies that assessed NLR in FMF patients and compared the value with normal controls. There was no time limitation. Finally, two researchers extracted data including first author name, publication year, the country, study design, number of patients and controls, time of disease diagnosis, FMF diagnostic criteria, mean age of the patients, and the NLR value. The data were systematically reviewed and meta-analyzed. In total, 464 articles were found on search; however, only 12 studies qualified for enrollment in the systematic review and 10 studies, with appropriate effect size, in the meta-analysis. These studies were conducted between 2013 and 2019. Eleven studies were conducted in Turkey and one in Egypt. Out of 12 studies, 9 had enrollment criteria for FMF patients: 8 studies used Tel Hashomer criteria and 1 study used Yalçinkaya–Özen criteria. All studies, except for two, had genetic confirmation for FMF. The mean NLR values in attack-free (standard difference in means = 0.482; p < 0.0001) and attack groups (standard difference in means = 0.853; p = 0.001) were significantly higher than control group. The mean NLR value may be related to the underlying inflammation in FMF.

Keywords

familial Mediterranean fever - neutrophil-to-lymphocyte ratio - inflammation

Volltext

Referenzen

References
1 Özen S. Update on the epidemiology and disease outcome of familial Mediterranean fever. Best Pract Res Clin Rheumatol 2018; 32 (02) 254-260
2 Cekin N, Akyurek ME, Pinarbasi E, Ozen F. MEFV mutations and their relation to major clinical symptoms of familial Mediterranean fever. Gene 2017; 626: 9-13
3 Touitou I. The spectrum of familial Mediterranean fever (FMF) mutations. Eur J Hum Genet 2001; 9 (07) 473-483
4 Ozdogan H, Ugurlu S. Familial Mediterranean fever. Presse Med 2019; 48 (1 Pt 2): e61-e76
5 Beheshtian M, Izadi N, Kriegshauser G. et al. Prevalence of common MEFV mutations and carrier frequencies in a large cohort of Iranian populations. J Genet 2016; 95 (03) 667-674
6 Sohar E, Gafni J, Pras M, Heller H. Familial Mediterranean fever. A survey of 470 cases and review of the literature. Am J Med 1967; 43 (02) 227-253
7 Barut K, Sahin S, Adrovic A. et al. Familial Mediterranean fever in childhood: a single-center experience. Rheumatol Int 2018; 38 (01) 67-74
8 Yildirim K, Uzkeser H, Keles M. et al. Relationship between serum interleukin-1β levels and acute phase response proteins in patients with familial Mediterranean fever. Biochem Med (Zagreb) 2012; 22 (01) 109-113
9 Uslu AU, Deveci K, Korkmaz S. et al. Is neutrophil/lymphocyte ratio associated with subclinical inflammation and amyloidosis in patients with familial Mediterranean fever?. BioMed Res Int 2013; 2013: 185317
10 Ben-Zvi I, Livneh A. Chronic inflammation in FMF: markers, risk factors, outcomes and therapy. Nat Rev Rheumatol 2011; 7 (02) 105-112
11 Xu S, Ma Y, Wu M. et al. Neutrophil lymphocyte ratio in patients with ankylosing spondylitis: a systematic review and meta-analysis. Mod Rheumatol 2020; 30 (01) 141-148
12 Erre GL, Paliogiannis P, Castagna F. et al. Meta-analysis of neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio in rheumatoid arthritis. Eur J Clin Invest 2019; 49 (01) e13037
13 Ma L, Zeng A, Chen B, Chen Y, Zhou R. Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in patients with systemic lupus erythematosus and their correlation with activity: a meta-analysis. Int Immunopharmacol 2019; 76: 105949
14 Ghodsi A, Mirimoghaddam MM, Sarabi M. et al. Neutrophil-to-lymphocyte ratio as a novel and valuable marker for assessing disease severity in ulcerative colitis, multiple sclerosis, and Kawasaki disease: a review. J Basic Res Med Sci 2020; 7 (03) 62-70
15 Zhang Z, Su Q, Zhang L, Yang Z, Qiu Y, Mo W. Diagnostic value of hemoglobin and neutrophil-to-lymphocyte ratio in Behcet disease. Medicine (Baltimore) 2019; 98 (52) e18443
16 Yorulmaz A, Akbulut H, Taş SA, Tıraş M, Yahya İ, Peru H. Evaluation of hematological parameters in children with FMF. Clin Rheumatol 2019; 38 (03) 701-707
17 Basaran O, Uncu N, Celikel BA, Aydın F, Cakar N. Assessment of neutrophil to lymphocyte ratio and mean platelet volume in pediatric familial Mediterranean fever patients. J Res Med Sci 2017; 22: 35
18 Kelesoglu FM, Aygun E, Okumus NK. et al. Evaluation of subclinical inflammation in familial Mediterranean fever patients: relations with mutation types and attack status: a retrospective study. Clin Rheumatol 2016; 35 (11) 2757-2763
19 Duksal F, Alaygut D, Güven AS. et al. Neutrophil-lymphocyte ratio in children with familial Mediterranean fever: original article. Eur J Rheumatol 2015; 2 (01) 20-23
20 Uluca Ü, Ece A, Şen V. et al. Usefulness of mean platelet volume and neutrophil-to-lymphocyte ratio for evaluation of children with familial Mediterranean fever. Med Sci Monit 2014; 20: 1578-1582
21 Moher D, Liberati A, Tetzlaff J, Altman DG. PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009; 6 (07) e1000097
22 Omranzadeh A, Baradaran A, Ghodsi A. et al. Comparing neutrophil to lymphocyte ratio between a group of familial Mediterranean fever (FMF) and a healthy control group. PROSPERO [Internet]. 2018 . Available from: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42018092613
23 JB Institute. JBI critical appraisal checklist for case control studies. Joanna Briggs Institute Reviewers' Manual. 2016
24 Kholoussi S, Kholoussi N, Zaki ME. et al. Immunological evaluation in patients with familial Mediterranean fever. Open Access Maced J Med Sci 2018; 6 (02) 310-313
25 Livneh A, Langevitz P, Zemer D. et al. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 1997; 40 (10) 1879-1885
26 Yalçinkaya F, Özen S, Ozçakar ZB. et al. A new set of criteria for the diagnosis of familial Mediterranean fever in childhood. Rheumatology (Oxford) 2009; 48 (04) 395-398
27 Daglar K, Kirbas A, Timur H. et al. Subclinical inflammation and simple blood parameters in pregnant with familial Mediterranean fever. J Clin Anal Med 2016; 7 (05) 634-638
28 Celikbilek M, Dogan S, Akyol L. et al. Neutrophil-lymphocyte ratio in patients with familial Mediterranean fever. J Clin Lab Anal 2015; 29 (01) 80-83
29 Özer S, Yılmaz R, Sönmezgöz E. et al. Simple markers for subclinical inflammation in patients with familial Mediterranean fever. Med Sci Monit 2015; 21: 298-303
30 Çakar M, Akhan M, Doğan T. et al. Investigation of the arterial stiffness and associated factors in patients with familial Mediterranean fever. Anatol J Cardiol 2017; 17 (02) 132-138
31 Ahsen A, Ulu MS, Yuksel S. et al. As a new inflammatory marker for familial Mediterranean fever: neutrophil-to-lymphocyte ratio. Inflammation 2013; 36 (06) 1357-1362
32 Bilginer Y, Akpolat T, Ozen S. Renal amyloidosis in children. Pediatr Nephrol 2011; 26 (08) 1215-1227
33 Savic S, Dickie LJ, Battellino M, McDermott MF. Familial Mediterranean fever and related periodic fever syndromes/autoinflammatory diseases. Curr Opin Rheumatol 2012; 24 (01) 103-112
34 Sakallı H, Kal O. Mean platelet volume as a potential predictor of proteinuria and amyloidosis in familial Mediterranean fever. Clin Rheumatol 2013; 32 (08) 1185-1190
35 Makay B, Türkyilmaz Z, Ünsal E. Mean platelet volume in children with familial Mediterranean fever. Clin Rheumatol 2009; 28 (08) 975-978
36 Sharaiha RZ, Halazun KJ, Mirza F. et al. Elevated preoperative neutrophil:lymphocyte ratio as a predictor of postoperative disease recurrence in esophageal cancer. Ann Surg Oncol 2011; 18 (12) 3362-3369
37 Azab B, Jaglall N, Atallah JP. et al. Neutrophil-lymphocyte ratio as a predictor of adverse outcomes of acute pancreatitis. Pancreatology 2011; 11 (04) 445-452
38 Gasparyan AY, Ayvazyan L, Mukanova U, Yessirkepov M, Kitas GD. The platelet-to-lymphocyte ratio as an inflammatory marker in rheumatic diseases. Ann Lab Med 2019; 39 (04) 345-357
39 Forget P, Khalifa C, Defour J-P, Latinne D, Van Pel M-C, De Kock M. What is the normal value of the neutrophil-to-lymphocyte ratio?. BMC Res Notes 2017; 10 (01) 12
40 Bray C, Bell LN, Liang H. et al. Erythrocyte sedimentation rate and C-reactive protein measurements and their relevance in clinical medicine. WMJ 2016; 115 (06) 317-321
41 Li J, Chen Q, Luo X. et al. Neutrophil-to-lymphocyte ratio positively correlates to age in healthy population. J Clin Lab Anal 2015; 29 (06) 437-443
42 Challis JR, Lockwood CJ, Myatt L, Norman JE, Strauss III JF, Petraglia F. Inflammation and pregnancy. Reprod Sci 2009; 16 (02) 206-215
43 Eviatar T, Zaks N, Kukuy O, Livneh A, Lidar M. PW01–010–The effect of pregnancy on disease course in FMF. Pediatr Rheumatol Online J 2013; 11 (Suppl. 01) A63
44 Karacan İ, Uğurlu S, Tolun A, Tahir Turanlı E, Ozdogan H. Other autoinflammatory disease genes in an FMF-prevalent population: a homozygous MVK mutation and a novel heterozygous TNFRSF1A mutation in two different Turkish families with clinical FMF. Clin Exp Rheumatol 2017; 35 (06) (Suppl. 108) 75-81
45 Samuels J, Aksentijevich I, Torosyan Y. et al. Familial Mediterranean fever at the millennium. Clinical spectrum, ancient mutations, and a survey of 100 American referrals to the National Institutes of Health. Medicine (Baltimore) 1998; 77 (04) 268-297
46 Booty MG, Chae JJ, Masters SL. et al. Familial Mediterranean fever with a single MEFV mutation: where is the second hit?. Arthritis Rheum 2009; 60 (06) 1851-1861
47 Balta S, Demirkol S, Unlu M, Arslan Z, Celik T. Neutrophil to lymphocyte ratio may be predict of mortality in all conditions. Br J Cancer 2013; 109 (12) 3125-3126
48 Corsia A, Georgin-Lavialle S, Hentgen V. et al. A survey of resistance to colchicine treatment for French patients with familial Mediterranean fever. Orphanet J Rare Dis 2017; 12 (01) 54
49 Soriano A, Manna R. Familial Mediterranean fever: new phenotypes. Autoimmun Rev 2012; 12 (01) 31-37
50 Stroka KM, Hayenga HN, Aranda-Espinoza H. Human neutrophil cytoskeletal dynamics and contractility actively contribute to trans-endothelial migration. PLoS One 2013; 8 (04) e61377